CLINICAL_TRIALS
trial_result
· 2019-12-20
Clinical Trial Update: A Trial of TTA-121 on Autism Spectrum Disorder [Phase 2]
Summary
Phase 2 clinical trial update for TTA-121 in Autism Spectrum Disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hamamatsu University | Conditions: Autism Spectrum Disorder | Phase 2 | Status: UNKNOWN